Literature DB >> 22995714

A selective medium for Rothia mucilaginosa and its distribution in oral cavities.

Taira Kobayashi1, Satoshi Uchibori, Osamu Tsuzukibashi, Haruhiko Goto, Masahiro Aida.   

Abstract

A selective medium for Rothia mucilaginosa (RMSM) was developed to examine the population of R. mucilaginosa in oral cavities. The growth recovery of R. mucilaginosa on RMSM was 85.1% relative to HI medium. R. mucilaginosa was detected at 3.4% of total bacteria from stimulated saliva of 8 subjects.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22995714     DOI: 10.1016/j.mimet.2012.09.011

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  5 in total

1.  Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.

Authors:  Avdhesh Kumar Rai; Madhusmita Panda; Ashok Kumar Das; Tashnin Rahman; Rajjyoti Das; Kishore Das; Anupam Sarma; Amal Ch Kataki; Indranil Chattopadhyay
Journal:  Arch Microbiol       Date:  2020-08-11       Impact factor: 2.552

2.  Complete Genome Sequence of Rothia mucilaginosa Strain NUM-Rm6536, Isolated from a Human Oral Cavity.

Authors:  Takayuki Nambu; Osamu Tsuzukibashi; Satoshi Uchibori; Chiho Mashimo
Journal:  Genome Announc       Date:  2015-10-01

3.  The Microbiome of Potentially Malignant Oral Leukoplakia Exhibits Enrichment for Fusobacterium, Leptotrichia, Campylobacter, and Rothia Species.

Authors:  Abdrazak Amer; Sheila Galvin; Claire M Healy; Gary P Moran
Journal:  Front Microbiol       Date:  2017-12-01       Impact factor: 5.640

4.  Developing selective media for quantification of multispecies biofilms following antibiotic treatment.

Authors:  Eva Vandeplassche; Tom Coenye; Aurélie Crabbé
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

5.  Acetaldehyde production by Rothia mucilaginosa isolates from patients with oral leukoplakia.

Authors:  Abdrazak Amer; Aine Whelan; Nezar N Al-Hebshi; Claire M Healy; Gary P Moran
Journal:  J Oral Microbiol       Date:  2020-03-21       Impact factor: 5.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.